Relationship between O6-alkylguanine-DNA alkyltransferase activity and N-methyl-N'-nitro-N-nitrosoguanidine-induced mutation, transformation, and cytotoxicity in C3H/10T1/2 cells expressing exogenous alkyltransferase genes
- PMID: 1454799
- PMCID: PMC50517
- DOI: 10.1073/pnas.89.23.11199
Relationship between O6-alkylguanine-DNA alkyltransferase activity and N-methyl-N'-nitro-N-nitrosoguanidine-induced mutation, transformation, and cytotoxicity in C3H/10T1/2 cells expressing exogenous alkyltransferase genes
Abstract
While a great deal of evidence has directly implicated the importance of O6-alkylation of guanine in the mutagenicity of alkylating agents, evidence demonstrating the oncogenic potential of this lesion has been largely indirect. We have combined a well-studied in vitro neoplastic transformation system (using C3H/10T1/2 mouse cells) with a proven method of gene transfection for expressing the bacterial O6-alkylguanine-DNA alkyltransferase (AT; EC 2.1.1.63) repair genes ada and ogt to generate subclones which possess augmented repair capability toward specific DNA lesions. The products of these genes specifically and differentially repair O6-methylguanine (O6-MeGua), O4-methylthymine (O4-MeThy), and methylphosphotriesters. We show that the level of expression of either the ada or the ogt AT gene in C3H/10T1/2 cells directly correlates with protection against mutation to ouabain resistance by N-methyl-N'-nitro-N-nitrosoguanidine (MNNG). Subclones expressing 70 fmol of AT per 10(6) cells exhibited a mutation frequency approximately 1/40th of that of clones expressing 15 fmol of AT per 10(6) cells when treated with MNNG at 0.4 micrograms/ml. Protection against mutagenesis by MNNG at 0.8 micrograms/ml, however, did not exceed 12-fold even in subclones expressing greater than 100 fmol of AT per 10(6) cells. As an MNNG dose of 0.6 micrograms/ml was sufficient to saturate more than 95% of the AT activity in any of the clones, the residual mutation frequency may have been caused by unrepaired O6MeGua lesions. In contrast to mutagenesis, protection against neoplastic transformation in vitro, in cells expressing high levels of AT, was most pronounced in cells treated with the highest dose of MNNG used (1.2 micrograms/ml). Low levels of transformation caused by MNNG at 0.4 and 0.8 micrograms/ml were not consistently inhibited in those clones. These data suggest that O6-MeGua formation is of major but not unique significance in the neoplastic transformation of C3H/10T1/2 cells by MNNG.
Similar articles
-
X-ray induction of O6-alkylguanine-DNA alkyltransferase protects against some of the biological effects of N-methyl-N'-nitro-N-nitrosoguanidine in C3H 10T1/2 cells.Radiat Res. 1991 Aug;127(2):220-5. Radiat Res. 1991. PMID: 1947007
-
Effect of O6-alkylguanine-DNA alkyltransferase on the frequency and spectrum of mutations induced by N-methyl-N'-nitro-N-nitrosoguanidine in the HPRT gene of diploid human fibroblasts.Mutat Res. 1991 Sep-Oct;250(1-2):397-409. doi: 10.1016/0027-5107(91)90196-u. Mutat Res. 1991. PMID: 1944354
-
Transfection and expression of human O6-methylguanine-DNA methyltransferase (MGMT) cDNA in Chinese hamster cells: the role of MGMT in protection against the genotoxic effects of alkylating agents.Carcinogenesis. 1991 Oct;12(10):1857-67. doi: 10.1093/carcin/12.10.1857. Carcinogenesis. 1991. PMID: 1657427
-
Contribution of O6-alkylguanine and N-alkylpurines to the formation of sister chromatid exchanges, chromosomal aberrations, and gene mutations: new insights gained from studies of genetically engineered mammalian cell lines.Environ Mol Mutagen. 1993;22(4):283-92. doi: 10.1002/em.2850220418. Environ Mol Mutagen. 1993. PMID: 8223512 Review.
-
Repair of DNA containing O6-alkylguanine.FASEB J. 1992 Mar;6(6):2302-10. doi: 10.1096/fasebj.6.6.1544541. FASEB J. 1992. PMID: 1544541 Review.
Cited by
-
Influence of O6-benzylguanine on the anti-tumour activity and normal tissue toxicity of 1,3-bis(2-chloroethyl)-1-nitrosourea and molecular combinations of 5-fluorouracil and 2-chloroethyl-1-nitrosourea in mice.Br J Cancer. 1999 Mar;79(9-10):1332-9. doi: 10.1038/sj.bjc.6690215. Br J Cancer. 1999. PMID: 10188873 Free PMC article.
-
Programming of Cell Resistance to Genotoxic and Oxidative Stress.Biomedicines. 2018 Jan 2;6(1):5. doi: 10.3390/biomedicines6010005. Biomedicines. 2018. PMID: 29301323 Free PMC article. Review.
-
The Escherichia coli AlkB protein protects human cells against alkylation-induced toxicity.J Bacteriol. 1994 Oct;176(20):6255-61. doi: 10.1128/jb.176.20.6255-6261.1994. J Bacteriol. 1994. PMID: 7928996 Free PMC article.
-
Live and let die: in vivo selection of gene-modified hematopoietic stem cells via MGMT-mediated chemoprotection.DNA Repair (Amst). 2007 Aug 1;6(8):1210-21. doi: 10.1016/j.dnarep.2007.03.020. Epub 2007 May 7. DNA Repair (Amst). 2007. PMID: 17482893 Free PMC article. Review.
-
Chemoprotection of normal tissues by transfer of drug resistance genes.Cancer Metastasis Rev. 1996 Sep;15(3):365-83. doi: 10.1007/BF00046348. Cancer Metastasis Rev. 1996. PMID: 9034597 Review.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous